05/30/2023
Tune in to WBZ / CBS News Boston for an insightful look into how MiNK is advancing novel allogeneic iNKT cell therapies for patients with solid tumor cancers.
New research shows promise for a new era of cell therapy designed to benefit patients with some of the most difficult-to-treat cancers.